Literature DB >> 16098221

The cholesterol-dependent cytolysin listeriolysin O aggregates rafts via oligomerization.

Nelson O Gekara1, Thomas Jacobs, Trinad Chakraborty, Siegfried Weiss.   

Abstract

The pore-forming toxin listeriolysin O (LLO) is the main virulence factor of Listeria monocytogenes. LLO is known to act as a pseudo cytokine/chemokine, which induces a broad spectrum of host responses that ultimately influences the outcome of listeriosis. In the present study we demonstrate that LLO is a potent aggregator of lipid rafts. LLO was found to aggregate the raft associated molecules GM1, the GPI-anchored proteins CD14 and CD16 as well as the tyrosine kinase Lyn. Abrogation of the cytolytic activity of LLO by cholesterol pretreatment was found not to interfere with LLO's ability to aggregate rafts or trigger tyrosine phosphorylation in cells. However, a monoclonal antibody that blocks the oligomerization of LLO was found to inhibit rafts' aggregation as well as the induction of tyrosine phosphorylation. This implies that rafts aggregation by LLO which is independent of cytolytic activity, is due to the oligomerization of its membrane bound toxin monomers. Thus, LLO most likely induces signalling through the coaggregation of rafts' associated receptors, kinases and adaptors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16098221     DOI: 10.1111/j.1462-5822.2005.00561.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  36 in total

Review 1.  Role of lipid rafts in liver health and disease.

Authors:  Angela Dolganiuc
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

2.  Perfringolysin O association with ordered lipid domains: implications for transmembrane protein raft affinity.

Authors:  Lindsay D Nelson; Salvatore Chiantia; Erwin London
Journal:  Biophys J       Date:  2010-11-17       Impact factor: 4.033

3.  Streptococcus pyogenes cytolysin-mediated translocation does not require pore formation by streptolysin O.

Authors:  N'Goundo Magassa; Sukantha Chandrasekaran; Michael G Caparon
Journal:  EMBO Rep       Date:  2010-03-26       Impact factor: 8.807

4.  Role of the lipopolysaccharide-CD14 complex for the activity of hemolysin from uropathogenic Escherichia coli.

Authors:  Lisa E Månsson; Peter Kjäll; Shahaireen Pellett; Gábor Nagy; Rodney A Welch; Fredrik Bäckhed; Teresa Frisan; Agneta Richter-Dahlfors
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

Review 5.  Intracellular lipid flux and membrane microdomains as organizing principles in inflammatory cell signaling.

Authors:  Michael B Fessler; John S Parks
Journal:  J Immunol       Date:  2011-08-15       Impact factor: 5.422

6.  Evidence that membrane rafts are not required for the action of Clostridium perfringens enterotoxin.

Authors:  Justin A Caserta; Martha L Hale; Michel R Popoff; Bradley G Stiles; Bruce A McClane
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

Review 7.  Lipids in the cell: organisation regulates function.

Authors:  Ana L Santos; Giulio Preta
Journal:  Cell Mol Life Sci       Date:  2018-02-09       Impact factor: 9.261

8.  Transmembrane protein (perfringolysin o) association with ordered membrane domains (rafts) depends upon the raft-associating properties of protein-bound sterol.

Authors:  Qingqing Lin; Erwin London
Journal:  Biophys J       Date:  2013-12-17       Impact factor: 4.033

9.  Multiple mechanisms contribute to the robust rapid gamma interferon response by CD8+ T cells during Listeria monocytogenes infection.

Authors:  Elsa N Bou Ghanem; Denise S McElroy; Sarah E F D'Orazio
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

10.  The Bordetella type III secretion system effector BteA contains a conserved N-terminal motif that guides bacterial virulence factors to lipid rafts.

Authors:  Christopher T French; Ekaterina M Panina; Sylvia H Yeh; Natasha Griffith; Diego G Arambula; Jeff F Miller
Journal:  Cell Microbiol       Date:  2009-07-24       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.